Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

CRISPR Therapeutics AG

CRSP · Nasdaq · CIK 0001674416 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

15 Form 4 transaction lines observed in the same window
7 sales · 8 option, withholding, award, gift or other lines

Last qualifying purchase2025-08-06 · Treco Douglas A · $1.1M

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
KASINGER JAMES R.General Counsel and Secretary
○▼○▼○▼
Kulkarni SamarthChief Executive Officer
○▼
Behbahani AliDirector
○▼
Patel NaimishChief Medical Officer
○▼
George SimeonDirector
○▼
Prasad RajuChief Financial Officer
○
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-08-06 · Treco Douglas A.

Recent Form 4 activity

0Purchases
29Sales
25Other Form 4 lines
24SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING7 sale line(s) · context only
OTHER8 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
18,679,198
Previous report
19,071,093
Avg daily volume
1,949,970
Days to cover
9.6

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-08-06Treco Douglas APurchase (P)Common Shares20,000USD 57.03USD 1,140,600SEC filing ↗
2025-07-16George SimeonPurchase (P)Common Shares989,812USD 52.03USD 51,499,918SEC filing ↗
2025-04-03Patel NaimishPurchase (P)Common Shares1,508USD 32.96USD 49,704SEC filing ↗
2025-02-26Greene JohnPurchase (P)Common Shares7,000USD 44.85USD 313,950SEC filing ↗

Form 4 evidence

54 transaction lines in the latest 365-day window; 556 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-14George SimeonSale (S)Common Shares14,514USD 49.63USD 720,373SEC filing ↗
2026-10-14George SimeonOption exercise / conversion (M)Common Shares30,000USD 14.00USD 420,000SEC filing ↗
2026-10-14Kulkarni SamarthSale (S)Common Shares4,098USD 49.26USD 201,867SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-14George SimeonSale (S)Common Shares14,514USD 49.63USD 720,373SEC filing ↗
2026-10-14George SimeonOption exercise / conversion (M)Common Shares30,000USD 14.00USD 420,000SEC filing ↗
2026-10-14Kulkarni SamarthSale (S)Common Shares4,098USD 49.26USD 201,867SEC filing ↗
2026-10-14KASINGER JAMES R.Sale (S)Common Shares1,040USD 49.26USD 51,230SEC filing ↗
2026-10-13Kulkarni SamarthOption exercise / conversion (M)Common Shares8,333USD —USD —SEC filing ↗
2026-10-13KASINGER JAMES R.Option exercise / conversion (M)Common Shares2,113USD —USD —SEC filing ↗
2026-10-06KASINGER JAMES R.Sale (S)Common Shares1,990USD 60.04USD 119,481SEC filing ↗
2026-10-06KASINGER JAMES R.Option exercise / conversion (M)Common Shares1,990USD 13.62USD 27,104SEC filing ↗
2026-09-22KASINGER JAMES R.Sale (S)Common Shares10,400USD 60.24USD 626,496SEC filing ↗
2026-09-22KASINGER JAMES R.Option exercise / conversion (M)Common Shares10,400USD 13.62USD 141,648SEC filing ↗
2026-09-17Behbahani AliSale (S)Common Shares13,679USD 57.09USD 780,934SEC filing ↗
2026-09-17Behbahani AliOption exercise / conversion (M)Common Shares30,000USD 14.00USD 420,000SEC filing ↗
2026-08-07Prasad RajuGift (G)Common Shares750USD 0.00USD 0SEC filing ↗
2026-05-29Patel NaimishSale (S)Common Shares3,786USD 55.62USD 210,577SEC filing ↗
2026-05-28Patel NaimishOption exercise / conversion (M)Common Shares10,000USD —USD —SEC filing ↗
2026-03-23Prasad RajuSale (S)Common Shares3,708USD 46.78USD 173,460SEC filing ↗
2026-03-23Kulkarni SamarthSale (S)Common Shares10,020USD 46.78USD 468,736SEC filing ↗
2026-03-23KASINGER JAMES R.Sale (S)Common Shares3,182USD 46.78USD 148,854SEC filing ↗
2026-03-20Prasad RajuOption exercise / conversion (M)Common Shares6,250USD —USD —SEC filing ↗
2026-03-20Kulkarni SamarthOption exercise / conversion (M)Common Shares19,687USD —USD —SEC filing ↗
2026-03-20KASINGER JAMES R.Option exercise / conversion (M)Common Shares6,250USD —USD —SEC filing ↗
2026-03-16Prasad RajuSale (S)Common Shares9,869USD 48.26USD 476,278SEC filing ↗
2026-03-16Prasad RajuGift (G)Common Shares750USD 0.00USD 0SEC filing ↗
2026-03-16Patel NaimishSale (S)Common Shares3,150USD 48.26USD 152,019SEC filing ↗
2026-03-16Kulkarni SamarthSale (S)Common Shares10,349USD 48.26USD 499,443SEC filing ↗
2026-03-16KASINGER JAMES R.Sale (S)Common Shares3,450USD 48.26USD 166,497SEC filing ↗
2026-03-14Prasad RajuOption exercise / conversion (M)Common Shares16,875USD —USD —SEC filing ↗
2026-03-14Patel NaimishOption exercise / conversion (M)Common Shares8,125USD —USD —SEC filing ↗
2026-03-14Kulkarni SamarthOption exercise / conversion (M)Common Shares20,625USD —USD —SEC filing ↗
2026-03-14KASINGER JAMES R.Option exercise / conversion (M)Common Shares6,875USD —USD —SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerCRSP
CIK0001674416
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2836 Biological Products, (No Diagnostic Substances)
ExchangeNasdaq

Data coverage

Local Form 4 history556 transaction lines from 2020-03-02 to 2026-10-14
6 P purchase lines · 300 S sale lines · 250 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.